Curative Ventures is a capital and talent partner to category-defining biotech companies that are developing new therapies to dramatically improve patient outcomes.
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
Proceeds will support clinical development of lead program TC-210 and [...]
CoStim Pharmaceuticals, Inc. Acquired by Novartis
BOSTON, Feb. 17, 2014 /PRNewswire/ -- MPM Capital and Atlas Venture announced today [...]